Salarius Pharmaceuticals (SLRX) Short Interest Ratio & Short Volume

$3.19

-0.31 (-8.86%)

(As of 07/26/2024 ET)

Compare

Salarius Pharmaceuticals Short Interest Data

Current Short Interest: 59,900 shares
Previous Short Interest: 19,000 shares
Change Vs. Previous Month: +215.26%
Dollar Volume Sold Short: $106,622.00
Short Interest Ratio: 0.0 Days to Cover
Last Record Date: July 15, 2024

Outstanding Shares: 600,000 shares
Float Size: 560,800 shares
Short Percent of Float: 10.68%
Today's Trading Volume: 1,272,293 shares
Average Trading Volume: 6,005,840 shares
Today's Volume Vs. Average: 21%

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Short Selling Salarius Pharmaceuticals ?

Sign up to receive the latest short interest report for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

SLRX Short Interest Over Time

SLRX Days to Cover Over Time

SLRX Percentage of Float Shorted Over Time

Ad Crypto Swap Profits

625,000% Gain

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

Salarius Pharmaceuticals Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
7/15/2024	59,900 shares	$106,622.00	+215.3%	10.7%	0	$1.78
6/30/2024	19,000 shares	$45,220.00	+375.0%	27.1%	0.9	$2.38
6/15/2024	4,000 shares	$13,526.40	-85.4%	5.7%	0.2	$3.38
5/31/2024	27,300 shares	$12,645.36	-18.5%	0.6%	0.2	$0.46
5/15/2024	33,500 shares	$15,343.00	-54.5%	0.8%	0.3	$0.46
4/30/2024	73,600 shares	$36,726.40	-36.3%	1.7%	0.6	$0.50
Get the Latest News and Ratings for SLRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Salarius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
4/15/2024	115,600 shares	$57,800.00	-57.0%	2.6%	1	$0.50
3/31/2024	268,900 shares	$142,140.54	+1,767.4%	6.7%	2.4	$0.53
3/15/2024	14,400 shares	$9,360.00	-20.0%	0.4%	0.1	$0.65
2/29/2024	18,000 shares	$12,060.00	+227.3%	0.5%	0.6	$0.67
2/15/2024	5,500 shares	$3,245.00	-33.7%	0.2%	0.2	$0.59
1/31/2024	8,300 shares	$4,556.70	+36.1%	0.2%	0.2	$0.55
1/15/2024	6,100 shares	$3,721.00	-37.1%	0.2%	0.2	$0.61
12/31/2023	9,700 shares	$6,305.00	+38.6%	0.3%	0.3	$0.65
12/15/2023	7,000 shares	$4,515.00	-71.9%	0.2%	0.1	$0.65
11/30/2023	24,900 shares	$17,679.00	-56.0%	0.7%	0.4	$0.71
11/15/2023	56,600 shares	$40,752.00	-22.7%	1.6%	1.1	$0.72
10/31/2023	73,200 shares	$61,334.28	+136.9%	2.3%	1.2	$0.84
10/15/2023	30,900 shares	$21,321.00	+62.6%	0.9%	0.5	$0.69
9/30/2023	19,000 shares	$12,500.08	-6.4%	0.6%	0.3	$0.66
9/15/2023	20,300 shares	$17,395.07	-26.5%	0.6%	0.4	$0.86
8/31/2023	27,600 shares	$24,285.24	+162.9%	0.8%	0.5	$0.88
8/15/2023	10,500 shares	$7,490.70	+54.4%	0.3%	0.2	$0.71
7/31/2023	6,800 shares	$6,249.20	-60.9%	0.2%	0.1	$0.92
7/15/2023	17,400 shares	$19,314.00	-44.8%	0.6%	0.2	$1.11
6/30/2023	31,500 shares	$46,935.00	-41.2%	1.0%	0.3	$1.49
6/15/2023	53,600 shares	$85,224.00	+9.6%	1.7%	0.5	$1.59
5/31/2023	48,900 shares	$68,949.00	-48.4%	2.1%	0.5	$1.41
5/15/2023	94,700 shares	$136,368.00	-16.1%	4.2%	1	$1.44
4/30/2023	112,800 shares	$200,784.00	-11.9%	5.4%	1.3	$1.78
4/15/2023	128,000 shares	$220,160.00	+6.1%	6.1%	2.5	$1.72
3/31/2023	120,700 shares	$230,537.00	-4.2%	5.8%	0.8	$1.91
3/15/2023	126,000 shares	$255,780.00	-4.0%	6.6%	0.7	$2.03
2/28/2023	131,300 shares	$279,669.00	+16.7%	6.8%	0.7	$2.13
2/15/2023	112,500 shares	$252,000.00	+11.3%	5.9%	0.6	$2.24
1/31/2023	101,100 shares	$260,838.00	+37.7%	5.2%	0.6	$2.58
1/15/2023	73,400 shares	$194,510.00	+272.6%	3.8%	0.4	$2.65
12/30/2022	19,700 shares	$30,141.00	-46.6%	1.0%	0.3	$1.53
12/15/2022	36,900 shares	$55,719.00	+93.2%	1.9%	0.8	$1.51
11/30/2022	19,100 shares	$36,863.00	-12.0%	1.0%	0.4	$1.93
New trading system called MSFT, NVDA & MSFT (Ad) Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today. Just follow this link here!
11/15/2022	21,700 shares	$46,655.00	+100.9%	1.1%	0.5	$2.15
10/31/2022	10,800 shares	$21,924.00	-31.2%	0.5%	0.3	$2.03
10/15/2022	15,700 shares	$71,042.50	-95.8%	0.8%	0.4	$4.53
9/30/2022	371,000 shares	$72,345.00	-8.4%	N/A	0.9	$0.20
9/15/2022	405,000 shares	$95,904.00	+9.6%	N/A	0.8	$0.24
8/31/2022	369,500 shares	$74,269.50	-16.3%	N/A	0.7	$0.20
8/15/2022	441,600 shares	$99,360.00	+257.3%	N/A	0.7	$0.23
7/31/2022	123,600 shares	$23,508.72	+7.3%	N/A	0.1	$0.19
7/15/2022	115,200 shares	$21,876.48	-33.8%	N/A	0.1	$0.19
6/30/2022	174,100 shares	$36,561.00	-54.6%	N/A	0.1	$0.21
6/15/2022	383,300 shares	$77,733.24	-9.8%	N/A	0.3	$0.20
5/31/2022	425,000 shares	$76,627.50	-3.8%	N/A	0.4	$0.18
5/15/2022	441,800 shares	$83,014.22	-26.6%	N/A	0.4	$0.19
4/30/2022	602,200 shares	$121,644.40	+31.4%	N/A	1.1	$0.20
4/15/2022	458,300 shares	$163,658.93	-14.7%	N/A	1.1	$0.36
3/31/2022	537,100 shares	$213,819.51	+11.7%	N/A	1.3	$0.40
3/15/2022	480,900 shares	$165,429.60	-23.8%	N/A	1	$0.34
2/28/2022	630,900 shares	$252,423.09	+0.4%	N/A	1.8	$0.40
2/15/2022	628,200 shares	$285,831.00	-3.7%	N/A	1.7	$0.46
1/31/2022	652,400 shares	$293,580.00	-2.0%	4.5%	1.5	$0.45
1/15/2022	665,600 shares	$312,832.00	+4.2%	4.6%	1.4	$0.47
12/31/2021	638,500 shares	$316,440.60	-7.3%	4.4%	1.3	$0.50
12/15/2021	688,600 shares	$365,853.18	-35.0%	4.7%	1.4	$0.53
11/30/2021	1,060,000 shares	$689,000.00	+1.0%	7.3%	1.5	$0.65
11/15/2021	1,050,000 shares	$796,950.00	+7.5%	7.2%	1.1	$0.76
10/29/2021	976,600 shares	$808,331.82	-0.2%	6.7%	0.8	$0.83
10/15/2021	978,900 shares	$886,002.39	-24.1%	6.7%	0.8	$0.91
9/30/2021	1,290,000 shares	$1.32 million	-4.4%	8.9%	1	$1.02
9/15/2021	1,350,000 shares	$1.39 million	-2.9%	9.3%	1	$1.03
8/31/2021	1,390,000 shares	$1.45 million	+9.5%	9.6%	1	$1.04
8/13/2021	1,270,000 shares	$1.17 million	-8.0%	8.8%	0.7	$0.92
7/30/2021	1,380,000 shares	$1.12 million	-9.2%	9.5%	0.8	$0.81
7/15/2021	1,520,000 shares	$1.38 million	-19.2%	10.5%	0.9	$0.91
6/30/2021	1,880,000 shares	$1.99 million	+0.5%	13.0%	1.1	$1.06
6/15/2021	1,870,000 shares	$2.24 million	+14.7%	12.9%	1.1	$1.20
5/28/2021	1,630,000 shares	$2.09 million	-2.4%	11.3%	1	$1.28
5/14/2021	1,670,000 shares	$2.04 million	+29.5%	N/A	1.3	$1.22
4/30/2021	1,290,000 shares	$1.72 million	-5.8%	N/A	0.6	$1.33
4/15/2021	1,370,000 shares	$1.78 million	-12.7%	N/A	0.6	$1.30
3/31/2021	1,570,000 shares	$2.25 million	+41.4%	N/A	0.6	$1.43
3/15/2021	1,110,000 shares	$1.81 million	-41.6%	N/A	0.4	$1.63
2/26/2021	1,900,000 shares	$3.67 million	+15.2%	N/A	0.7	$1.93
2/12/2021	1,650,000 shares	$4.36 million	+202.6%	N/A	0.6	$2.64
1/29/2021	545,200 shares	$594,268.00	-11.3%	N/A	0.3	$1.09
1/15/2021	614,300 shares	$712,588.00	+7.3%	N/A	0.6	$1.16
12/31/2020	572,800 shares	$510,937.60	+22.8%	N/A	0.7	$0.89
12/15/2020	466,600 shares	$407,295.14	-2.1%	N/A	0.8	$0.87
11/30/2020	476,400 shares	$325,857.60	-18.6%	N/A	1.1	$0.68
11/15/2020	585,000 shares	$427,050.00	+3.0%	N/A	3.9	$0.73
10/30/2020	568,000 shares	$382,434.40	-11.4%	N/A	3.6	$0.67
New trading system called MSFT, NVDA & MSFT (Ad) Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today. Just follow this link here!
10/15/2020	640,800 shares	$583,128.00	-5.2%	N/A	2.8	$0.91
9/30/2020	675,900 shares	$570,392.01	+22.7%	N/A	2.9	$0.84
9/15/2020	551,100 shares	$506,736.45	-4.2%	N/A	2.2	$0.92
8/31/2020	575,000 shares	$540,500.00	+1.4%	N/A	1.6	$0.94
8/14/2020	567,000 shares	$569,835.00	-40.8%	N/A	1	$1.01
7/31/2020	958,000 shares	$1.10 million	+3.7%	N/A	1.4	$1.15
7/15/2020	924,200 shares	$1.22 million	-6.1%	N/A	1.3	$1.32
6/30/2020	984,200 shares	$1.30 million	+0.6%	N/A	1.4	$1.32
6/15/2020	978,400 shares	$1.50 million	+48.5%	N/A	1.4	$1.53
5/29/2020	659,000 shares	$691,950.00	+120.0%	N/A	1.1	$1.05
5/15/2020	299,600 shares	$254,689.96	+14.5%	N/A	0.7	$0.85
4/30/2020	261,700 shares	$217,237.17	+38.0%	N/A	0.6	$0.83
4/15/2020	189,600 shares	$117,589.92	+83.5%	N/A	0.6	$0.62
3/31/2020	103,300 shares	$65,079.00	+37.4%	N/A	0.4	$0.63
3/13/2020	75,200 shares	$51,888.00	+89.4%	N/A	0.3	$0.69
2/28/2020	39,700 shares	$24,614.00	+146.6%	N/A	0.1	$0.62
2/14/2020	16,100 shares	$12,558.00	-89.4%	0.5%	0.1	$0.78
1/31/2020	151,700 shares	$131,979.00	+89.9%	4.8%	0.9	$0.87
1/15/2020	79,900 shares	$67,116.00	-24.4%	2.5%	1.2	$0.84
12/31/2019	105,700 shares	$288,561.00	+101.7%	3.7%	1.8	$2.73

SLRX Short Interest - Frequently Asked Questions

What is Salarius Pharmaceuticals' current short interest?: Short interest is the volume of Salarius Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 59,900 shares of SLRX short. 10.68% of Salarius Pharmaceuticals' shares are currently sold short. Learn More on Salarius Pharmaceuticals' current short interest.
What is a good short interest percentage for Salarius Pharmaceuticals?: Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.68% of Salarius Pharmaceuticals' floating shares are currently sold short.
Is Salarius Pharmaceuticals' short interest increasing or decreasing?: Salarius Pharmaceuticals saw a increase in short interest in July. As of July 15th, there was short interest totaling 59,900 shares, an increase of 215.3% from the previous total of 19,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
What is Salarius Pharmaceuticals' float size?: Salarius Pharmaceuticals currently has issued a total of 600,000 shares. Some of Salarius Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Salarius Pharmaceuticals currently has a public float of 560,800 shares.

How does Salarius Pharmaceuticals' short interest compare to its competitors?: 10.68% of Salarius Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Salarius Pharmaceuticals: Phio Pharmaceuticals Corp. (1.17%), MedAvail Holdings, Inc. (0.88%), Kazia Therapeutics Limited (20.69%), Bionomics Limited (1.82%), FSD Pharma Inc. (0.12%), GeoVax Labs, Inc. (5.29%), Alaunos Therapeutics, Inc. (9.66%), Pasithea Therapeutics Corp. (0.55%), Adial Pharmaceuticals, Inc. (3.71%), TFF Pharmaceuticals, Inc. (4.71%),
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.
What does it mean to sell short Salarius Pharmaceuticals stock?: Short selling SLRX is an investing strategy that aims to generate trading profit from Salarius Pharmaceuticals as its price is falling. SLRX shares are trading down $0.31 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Salarius Pharmaceuticals?: A short squeeze for Salarius Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SLRX, which in turn drives the price of the stock up even further.
How often is Salarius Pharmaceuticals' short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SLRX, twice per month. The most recent reporting period available is July, 15 2024.